ARTICLE | Company News
Cellomics, Discovery Partners deal
September 4, 2001 7:00 AM UTC
DPII will use Cellomics' ArrayScan high content screening (HCS) system, a cell-based assay to measure cellular responses to chemical compounds, in its drug discovery services. ...